Literature DB >> 11245614

Activation of K+ channels induces apoptosis in vascular smooth muscle cells.

S Krick1, O Platoshyn, M Sweeney, H Kim, J X Yuan.   

Abstract

Intracellular K+ plays an important role in controlling the cytoplasmic ion homeostasis for maintaining cell volume and inhibiting apoptotic enzymes in the cytosol and nucleus. Cytoplasmic K+ concentration is mainly regulated by K+ uptake via Na+-K+-ATPase and K+ efflux through K+ channels in the plasma membrane. Carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP), a protonophore that dissipates the H+ gradient across the inner membrane of mitochondria, induces apoptosis in many cell types. In rat and human pulmonary artery smooth muscle cells (PASMC), FCCP opened the large-conductance, voltage- and Ca2+-sensitive KK+ (maxi-K) channels, increased K+ currents through maxi-K channels [I(K(Ca))], and induced apoptosis. Tetraethylammonia (1 mM) and iberiotoxin (100 nM) decreased I(K(Ca)) by blocking the sarcolemmal maxi-K channels and inhibited the FCCP-induced apoptosis in PASMC cultured in media containing serum and growth factors. Furthermore, inhibition of K+ efflux by raising extracellular K+ concentration from 5 to 40 mM also attenuated PASMC apoptosis induced by FCCP and the K+ ionophore valinomycin. These results suggest that FCCP-mediated apoptosis in PASMC is partially due to an increase of maxi-K channel activity. The resultant K+ loss through opened maxi-K channels may serve as a trigger for cell shrinkage and caspase activation, which are major characteristics of apoptosis in pulmonary vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245614     DOI: 10.1152/ajpcell.2001.280.4.C970

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  40 in total

1.  Regulation of ion fluxes, cell volume and gap junctional coupling by cGMP in GFSHR-17 granulosa cells.

Authors:  A Ngezahayo; B Altmann; H-A Kolb
Journal:  J Membr Biol       Date:  2003-08-01       Impact factor: 1.843

Review 2.  The role of apoptotic volume decrease and ionic homeostasis in the activation and repression of apoptosis.

Authors:  Carl D Bortner; John A Cidlowski
Journal:  Pflugers Arch       Date:  2004-04-24       Impact factor: 3.657

Review 3.  Pulmonary Hypertension and ATP-Sensitive Potassium Channels.

Authors:  Conor McClenaghan; Kel Vin Woo; Colin G Nichols
Journal:  Hypertension       Date:  2019-05-28       Impact factor: 10.190

4.  Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts.

Authors:  Martin B Friis; Christel R Friborg; Linda Schneider; Maj-Britt Nielsen; Ian H Lambert; Søren T Christensen; Else K Hoffmann
Journal:  J Physiol       Date:  2005-06-23       Impact factor: 5.182

Review 5.  K+ channels in apoptosis.

Authors:  E D Burg; C V Remillard; J X-J Yuan
Journal:  J Membr Biol       Date:  2006-04-17       Impact factor: 1.843

Review 6.  One hundred years of research in the pathogenesis of pulmonary hypertension.

Authors:  Ari Zaiman; Iwona Fijalkowska; Paul M Hassoun; Rubin M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11       Impact factor: 6.914

Review 7.  Cell shrinkage and monovalent cation fluxes: role in apoptosis.

Authors:  Carl D Bortner; John A Cidlowski
Journal:  Arch Biochem Biophys       Date:  2007-02-08       Impact factor: 4.013

Review 8.  Vascular large conductance calcium-activated potassium channels: functional role and therapeutic potential.

Authors:  Birgit Eichhorn; Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-12       Impact factor: 3.000

9.  Stratified corneal limbal epithelial cells are protected from UVB-induced apoptosis by elevated extracellular K⁺.

Authors:  Mark P Schotanus; Leah R Koetje; Rachel E Van Dyken; John L Ubels
Journal:  Exp Eye Res       Date:  2011-10-14       Impact factor: 3.467

Review 10.  High altitude pulmonary hypertension: role of K+ and Ca2+ channels.

Authors:  Carmelle V Remillard; Jason X-J Yuan
Journal:  High Alt Med Biol       Date:  2005       Impact factor: 1.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.